You are here

Drug-resistant cancer responds to personalized drug combinations

Editage Insights | 2014年11月14日 | 3,897 浏览次数
Default Alt text

Cancer researcher and physician Jeffrey Engelman of the Massachusetts General Hospital in Boston has found a promising way of treating drug-resistant cancer by growing patients’ tumor cells and testing various drug combinations on them to find a way of effective treatment. Engelman and his colleagues devised a way to culture lung cancer cells from patient samples and then test them against a battery of 76 different drugs; and they got encouraging results. According to the researcher, this cell-culture model could make personalized drug screening faster as compared to using a mouse model. However, the team reported that they got unexpected results during their study; for example, cell samples that were resistant to therapies targeting a protein called ALK were felled by different drugs that inhibited another protein called SRC. Further research is required before this treatment can be used for patients.

Read more in Nature.    


《意得辑专家视点》深信知识需要开放给所有大众并传播,因此我们鼓励读者重复发表我们的内容,重复发表形式可为在线或印刷。我们采用知识共享(Creative Commons license),只要您遵守以下事项,即可免费重复发表我们的内容:
  • 作者信息:请尊重我们的作者,他们花费了时间精力为您撰写这些有价值的内容,重复发表时加注作者信息。
  • 意得辑专家视点:必须注明文章出自《意得辑专家视点》。
  • 表达您的情意:您可以加句“前往《意得辑专家视点》阅读全文”之类的话,啊,还有,别忘了加上文章链接。
  • 重复使用图片:要使用某些文章的图片必须事先取得许可,并加注图片原始出处。
  • 镶嵌代码:要重复使用这篇文章最简单的方式就是将下面的代码复制贴上您的页面!